Zacks Investment Research on MSN
FDA accepts BridgeBio's filing for rare genetic disease drug
BridgeBio Pharma BBIO announced that the FDA has accepted its regulatory filing seeking approval for the investigational oral candidate encaleret to treat individuals living with a rare genetic ...
Morning Overview on MSN
Your vitamin D may do nothing without enough magnesium, researchers find
Adults who take vitamin D supplements without adequate magnesium may be getting far less benefit than they expect. A ...
In the CALIBRATE trial, 76% of encaleret-treated patients normalized both blood and urine calcium at week 24 vs 4% on standard of care, while 91% achieved intact PTH restoration.
A phenotype-based approach to CaHA use in facial rejuvenation treatments was associated with greater improvements across ...
If approved, encaleret will be the first and only approved therapy specifically indicated for individuals living with ADH1, representing a potential blockbuster opportunity for BridgeBio - Encaleret ...
What happens to your liver when you take vitamin D supplements every day? Learn how vitamin D is processed by the liver, ...
Perhaps for this reason, my primary care physician ordered a DEXA scan in 2023 and again in 2026. I was alarmed when the ...
CARE Hospitals successfully treated a rare case of primary hyperparathyroidism after a routine screening detected the hidden ...
Brown tumours represent a rare manifestation of hyperparathyroidism, with mandibular involvement being exceptionally uncommon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results